STAT3 Signaling Pathway Promotes MMP-14 Expression in TNBC: A Comprehensive Review

Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression. TNBC accounts for a significant proportion of breast cancer cases and exhibits a poor prognosis, making it crucial to investigate its pathogenesis and identify potential therapeutic targets. STAT3 (signal transducer and activator of transcription 3), a pivotal transcription factor, plays a crucial role in various cancers, including TNBC.

This article delves into the intricate mechanisms by which the STAT3 signaling pathway promotes the expression of matrix metalloproteinase-14 (MMP-14) in TNBC. MMP-14, also known as membrane type 1 matrix metalloproteinase (MT1-MMP), is a vital matrix metalloproteinase primarily localized on the cell membrane. It participates in biological processes such as cell migration, invasion, and metastasis by degrading extracellular matrix proteins. The overexpression of MMP-14 is associated with tumor invasion and metastasis, highlighting the importance of understanding its regulatory mechanisms in TNBC.

STAT3, a ubiquitously expressed transcription factor in numerous cell types, becomes activated through the stimulation of extracellular signaling molecules. Its activation is primarily assessed by the presence of its phosphorylated form (pSTAT3). Once phosphorylated, STAT3 translocates to the nucleus and binds to specific DNA sequences, thereby regulating the transcription of a wide array of genes. Aberrant activation of the STAT3 signaling pathway in TNBC is implicated in tumor proliferation, invasion, and metastasis.

The STAT3 signaling pathway regulates MMP-14 expression through multiple pathways in TNBC. Firstly, phosphorylated STAT3 directly binds to the MMP-14 gene promoter region, stimulating its transcription. Studies have revealed that STAT3 interacts with specific sequences within the MMP-14 gene promoter, enhancing its transcriptional activity. Secondly, STAT3 indirectly regulates MMP-14 expression by modulating the expression of other transcription factors. For instance, STAT3 can promote the expression of the transcription factor Snail, a known transcriptional repressor of MMP-14. Therefore, STAT3 indirectly promotes MMP-14 expression by regulating Snail expression.

Beyond directly controlling MMP-14 transcription, STAT3 can also indirectly regulate MMP-14 expression by modulating MMP-14 transcription factors and signaling pathways. For example, STAT3 can influence MMP-14 transcription by regulating the expression of the transcription factor AP-1. AP-1 is a crucial transcription factor that binds to the MMP-14 gene promoter and promotes its transcription. Studies have demonstrated that STAT3 can directly bind to subunits of AP-1 and regulate their expression. Furthermore, STAT3 can affect MMP-14 expression by modulating other signaling pathways. For instance, STAT3 can promote the activation of the epidermal growth factor receptor (EGFR) signaling pathway, which is a major regulatory pathway for MMP-14. By regulating EGFR signaling activation, STAT3 indirectly influences MMP-14 expression.

In addition to modulating MMP-14 expression, the STAT3 signaling pathway contributes to TNBC development and progression through other mechanisms. Research suggests that aberrant activation of the STAT3 signaling pathway is closely associated with tumor proliferation, invasion, and metastasis. STAT3 can promote tumor cell proliferation by regulating the expression of cell cycle-related proteins. Moreover, STAT3 can influence tumor cell apoptosis by regulating the expression of apoptosis-related factors. Studies have shown that STAT3 can inhibit the expression of the apoptosis-related factor Bcl-2, thereby suppressing tumor cell apoptosis. Furthermore, STAT3 can promote tumor progression by facilitating tumor cell invasion and metastasis. Research has shown that STAT3 can promote the expression and activity of matrix metalloproteinases, leading to the degradation of the extracellular matrix and promoting tumor cell invasion and metastasis.

In conclusion, the STAT3 signaling pathway promotes MMP-14 expression through multiple mechanisms, playing a crucial role in TNBC development and progression. Understanding how the STAT3 signaling pathway regulates MMP-14 expression not only enhances our comprehension of TNBC pathogenesis but also offers novel therapeutic targets and strategies for TNBC treatment.